Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease

There is concern that the global burden of coronavirus disease of 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection might yield an increased occurrence of Guillain-Barré syndrome (GBS). It is currently unknown whether concomitant SARS-CoV-2 infection and G...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrams, Rory M.C., Kim, Brian D., Markantone, Desiree M., Reilly, Kaitlin, Paniz-Mondolfi, Alberto E., Gitman, Melissa R., Choo, S. Yoon, Tse, Winona, Robinson-Papp, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384559/
https://www.ncbi.nlm.nih.gov/pubmed/32720233
http://dx.doi.org/10.1007/s13365-020-00884-7
_version_ 1783563626776363008
author Abrams, Rory M.C.
Kim, Brian D.
Markantone, Desiree M.
Reilly, Kaitlin
Paniz-Mondolfi, Alberto E.
Gitman, Melissa R.
Choo, S. Yoon
Tse, Winona
Robinson-Papp, Jessica
author_facet Abrams, Rory M.C.
Kim, Brian D.
Markantone, Desiree M.
Reilly, Kaitlin
Paniz-Mondolfi, Alberto E.
Gitman, Melissa R.
Choo, S. Yoon
Tse, Winona
Robinson-Papp, Jessica
author_sort Abrams, Rory M.C.
collection PubMed
description There is concern that the global burden of coronavirus disease of 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection might yield an increased occurrence of Guillain-Barré syndrome (GBS). It is currently unknown whether concomitant SARS-CoV-2 infection and GBS are pathophysiologically related, what biomarkers are useful for diagnosis, and what is the optimal treatment given the medical comorbidities, complications, and simultaneous infection. We report a patient who developed severe GBS following SARS-CoV-2 infection at the peak of the initial COVID-19 surge (April 2020) in New York City and discuss diagnostic and management issues and complications that may warrant special consideration in similar patients.
format Online
Article
Text
id pubmed-7384559
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73845592020-07-28 Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease Abrams, Rory M.C. Kim, Brian D. Markantone, Desiree M. Reilly, Kaitlin Paniz-Mondolfi, Alberto E. Gitman, Melissa R. Choo, S. Yoon Tse, Winona Robinson-Papp, Jessica J Neurovirol Case Report There is concern that the global burden of coronavirus disease of 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection might yield an increased occurrence of Guillain-Barré syndrome (GBS). It is currently unknown whether concomitant SARS-CoV-2 infection and GBS are pathophysiologically related, what biomarkers are useful for diagnosis, and what is the optimal treatment given the medical comorbidities, complications, and simultaneous infection. We report a patient who developed severe GBS following SARS-CoV-2 infection at the peak of the initial COVID-19 surge (April 2020) in New York City and discuss diagnostic and management issues and complications that may warrant special consideration in similar patients. Springer International Publishing 2020-07-27 2020 /pmc/articles/PMC7384559/ /pubmed/32720233 http://dx.doi.org/10.1007/s13365-020-00884-7 Text en © Journal of NeuroVirology, Inc. 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Abrams, Rory M.C.
Kim, Brian D.
Markantone, Desiree M.
Reilly, Kaitlin
Paniz-Mondolfi, Alberto E.
Gitman, Melissa R.
Choo, S. Yoon
Tse, Winona
Robinson-Papp, Jessica
Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease
title Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease
title_full Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease
title_fullStr Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease
title_full_unstemmed Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease
title_short Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease
title_sort severe rapidly progressive guillain-barré syndrome in the setting of acute covid-19 disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384559/
https://www.ncbi.nlm.nih.gov/pubmed/32720233
http://dx.doi.org/10.1007/s13365-020-00884-7
work_keys_str_mv AT abramsrorymc severerapidlyprogressiveguillainbarresyndromeinthesettingofacutecovid19disease
AT kimbriand severerapidlyprogressiveguillainbarresyndromeinthesettingofacutecovid19disease
AT markantonedesireem severerapidlyprogressiveguillainbarresyndromeinthesettingofacutecovid19disease
AT reillykaitlin severerapidlyprogressiveguillainbarresyndromeinthesettingofacutecovid19disease
AT panizmondolfialbertoe severerapidlyprogressiveguillainbarresyndromeinthesettingofacutecovid19disease
AT gitmanmelissar severerapidlyprogressiveguillainbarresyndromeinthesettingofacutecovid19disease
AT choosyoon severerapidlyprogressiveguillainbarresyndromeinthesettingofacutecovid19disease
AT tsewinona severerapidlyprogressiveguillainbarresyndromeinthesettingofacutecovid19disease
AT robinsonpappjessica severerapidlyprogressiveguillainbarresyndromeinthesettingofacutecovid19disease

Ejemplares similares